chrX-85107369-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001367857.2(SATL1):c.1600G>A(p.Ala534Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000301 in 1,098,102 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 16 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 25)
Exomes 𝑓: 0.000030 ( 0 hom. 16 hem. )
Consequence
SATL1
NM_001367857.2 missense
NM_001367857.2 missense
Scores
1
4
12
Clinical Significance
Conservation
PhyloP100: 0.751
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.13332465).
BS2
High Hemizygotes in GnomAdExome4 at 16 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SATL1 | NM_001367857.2 | c.1600G>A | p.Ala534Thr | missense_variant | 3/8 | ENST00000644105.2 | |
SATL1 | NM_001367858.2 | c.1600G>A | p.Ala534Thr | missense_variant | 7/12 | ||
SATL1 | NM_001012980.2 | c.1600G>A | p.Ala534Thr | missense_variant | 1/5 | ||
SATL1 | XM_047442081.1 | c.1600G>A | p.Ala534Thr | missense_variant | 2/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SATL1 | ENST00000644105.2 | c.1600G>A | p.Ala534Thr | missense_variant | 3/8 | NM_001367857.2 | A2 |
Frequencies
GnomAD3 genomes Cov.: 25
GnomAD3 genomes
Cov.:
25
GnomAD3 exomes AF: 0.0000928 AC: 17AN: 183271Hom.: 0 AF XY: 0.000162 AC XY: 11AN XY: 67749
GnomAD3 exomes
AF:
AC:
17
AN:
183271
Hom.:
AF XY:
AC XY:
11
AN XY:
67749
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000301 AC: 33AN: 1098102Hom.: 0 Cov.: 30 AF XY: 0.0000440 AC XY: 16AN XY: 363462
GnomAD4 exome
AF:
AC:
33
AN:
1098102
Hom.:
Cov.:
30
AF XY:
AC XY:
16
AN XY:
363462
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 25
GnomAD4 genome
Cov.:
25
Bravo
AF:
ExAC
AF:
AC:
17
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 05, 2023 | The c.1600G>A (p.A534T) alteration is located in exon 1 (coding exon 1) of the SATL1 gene. This alteration results from a G to A substitution at nucleotide position 1600, causing the alanine (A) at amino acid position 534 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;.
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;T;T;.;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;.;.;.;.
MutationTaster
Benign
N;N;N
PrimateAI
Benign
T
PROVEAN
Uncertain
D;N;.;.;.
REVEL
Benign
Sift
Uncertain
D;D;.;.;.
Sift4G
Benign
T;T;.;.;.
Polyphen
D;.;.;.;.
Vest4
MutPred
Gain of phosphorylation at A347 (P = 0.042);.;.;.;.;
MVP
MPC
0.30
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at